A. Amico

Tumor genome analysis includes germline genome: Are we ready for surprises?

O. Olopade, J. Fackenthal, C. Gulden, 2014, International journal of cancer.

Long-Term Disease-Free Survival in a Young Patient With Hormone Receptor-Positive Breast Cancer and Oligometastatic Disease in the Brain.

O. Olopade, Poornima Saha, A. Amico, 2016, Clinical Breast Cancer.

Leptomeningeal Carcinomatosis from Pancreatic Cancer Associated With Germline BRCA Mutations: Case Reports and Review of the Literature

H. Kindler, A. Amico, R. Lukas, 2016 .

Clinical Assessment of 5-Fluorouracil/Leucovorin, Nab-Paclitaxel, and Irinotecan (FOLFIRABRAX) in Untreated Patients with Gastrointestinal Cancer Using UGT1A1 Genotype–Guided Dosing

T. Karrison, M. Zalupski, A. Sadiq, 2019, Clinical Cancer Research.

Utilization of Complementary Alternative Medicine, Diet, and Exercise Among Women at High Risk for Developing Breast Cancer

O. Olopade, L. Patrick-Miller, A. Bradbury, 2020, Integrative cancer therapies.

The shed P2X7 receptor is an index of adverse clinical outcome in COVID-19 patients

F. Di Virgilio, A. Passaro, A. Giuliani, 2023, Frontiers in Immunology.

Personalized antibodies for gastroesophageal adenocarcinoma (PANGEA): A phase II precision medicine trial (NCT02213289).

H. Kindler, B. Polite, A. Amico, 2018 .